Married woman hospitalized after 'rape attempt' by neighbor

[email protected] (CD Network, Photos by Savitha B.R)
July 14, 2011

Mangalore, July 14: A mother of a small baby was admitted to a private hospital in the city following the alleged rape attempt by a young man from her neighbourhood at Kukkatte in Ganjimutt, near here.

The incident occurred on Thursday morning when the woman was alone with her child at home.

One of the relatives of the woman said that one Azharuddin, who was known to the victim, knocked the door in the pretext of asking a few onions and tomatoes for cooking.

“When the woman handed over the same, the accused told her that he wanted to see the baby. Without knowing the foul intention of the neighbour boy, she turned to bring the baby. Seizing this opportunity he grabbed the woman from behind and misbehaved with her,” he said.

He said that when the helpless woman began to scream for help, the accused fled.

The relative said that the woman was not only injured but also suffered psychological shock due to the incident.


Bajpe police have launched a manhunt for the accused after registering a case.

scs1

scs2

scs3

scs4

scs5

scs6

scs7

scs8

scs9

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 22,2020

Bengaluru, Jul 22: A 54-year-old man committed suicide at his home, after he learned that he was tested positive for Covid-19, at Devasandra, in Sadashivanagar.

The deceased, Shivamahadeva, ran a cot shop in Yeshwantpur along with his brother. The police said that he was single and was living with his elder brother and his family.

In another incident, a 50-year-old man, committed suicide fearing Covid-19 and the stigma related to the illness.

The deceased has been identified as Nagaraju, a resident of Doddaballapura and a native of Hesaraghatta, and his body was found at the Hesaraghatta lake.

The police said that during the investigation it was found that the neighbours had accused Nagaraju of spreading the infection.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
August 9,2020

Bengaluru, Aug 9: A youth was killed and three others injured as a pillar of an old temple on the outskirts of Bengaluru fell on them as they and five others dug under it in search of treasure, police said on Saturday.

"One treasure hunter got crushed under a pillar, three suffered injuries and have been hospitalised while five are on the run," a police official said.

The incident occurred at a centuries-old Anjaneya temple in Hindiganala village near Hoskote, around 50 km away from the city, on Thursday night.

Suresh, 23, got crushed to death while Manjunath, 23, Srinivas, 22, and Sebastian Raja Rathna, 22, were injured.

Following the unexpected accident, the injured treasure hunters called a 108 ambulance, leading to the entire incident coming to light.

The ambulance staff helped the youth stuck under the temple pillars and took them to hospital.

Police have registered a case under various sections of the Ancient Monuments Act, the Karnataka Treasure Trove Act, and the Indian Penal Code.

According to the official, local youth the village as well as a nearby village were involved in the hunt.

Police are on the lookout for the five treasure hunters on the run.

However, the police official said that it was an old ruined temple and there was nothing there.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.